Literature DB >> 21122926

Neurocognition and recovery in first episode psychosis.

Gunnar Faber1, Henderikus G O M Smid, Arthur R Van Gool, Lex Wunderink, Durk Wiersma, Robert J van den Bosch.   

Abstract

Cognitive functioning has been found to be a predictor of functional outcome of schizophrenia. It is unclear, however, whether clinical recovery can be predicted by scores on specific cognitive domains. The predictive value of specific neurocognitive domains and other clinical variables for symptomatic and functional outcome and clinical recovery after a 2-year follow-up is explored in a group of 51 patients with non-affective first-episode psychosis. A comprehensive neurocognitive battery was administered 18 and 41weeks after inclusion. Other patient characteristics, which were expected to independently predict clinical recovery, were assessed at baseline. Several neurocognitive tests, especially tests measuring speed of processing, and among others, Duration of Untreated Psychosis (DUP), were significant predictors of clinical recovery. Poor neuropsychological performance accurately predicted non-recovery, but improved neuropsychological performance did not accurately predict recovery. This study confirms previous findings of an association between neurocognition and outcome, but the results also suggest that in order to accurately predict recovery, the role of other factors needs to be investigated.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21122926     DOI: 10.1016/j.psychres.2010.11.010

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  7 in total

1.  Untreated illness and recovery in clients of an early psychosis intervention program: a 10-year prospective cohort study.

Authors:  Gina Bhullar; Ross M G Norman; Neil Klar; Kelly K Anderson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-11-29       Impact factor: 4.328

2.  Abnormal resting state FMRI activity predicts processing speed deficits in first-episode psychosis.

Authors:  Miklos Argyelan; Juan A Gallego; Delbert G Robinson; Toshikazu Ikuta; Deepak Sarpal; Majnu John; Peter B Kingsley; John Kane; Anil K Malhotra; Philip R Szeszko
Journal:  Neuropsychopharmacology       Date:  2015-01-08       Impact factor: 7.853

3.  Psychomotor Slowing in Schizophrenia: Implications for Endophenotype and Biomarker Development.

Authors:  K Juston Osborne; Sebastian Walther; Stewart A Shankman; Vijay A Mittal
Journal:  Biomark Neuropsychiatry       Date:  2020-05-12

4.  Antipsychotic Maintenance Treatment: Time to Rethink?

Authors:  Joanna Moncrieff
Journal:  PLoS Med       Date:  2015-08-04       Impact factor: 11.069

5.  Poor premorbid school performance, but not severity of illness, predicts cognitive decline in schizophrenia in midlife.

Authors:  Irina Rannikko; Graham K Murray; Pauliina Juola; Henri Salo; Marianne Haapea; Jouko Miettunen; Juha Veijola; Jennifer H Barnett; Anja P Husa; Peter B Jones; Marjo-Riitta Järvelin; Matti Isohanni; Erika Jääskeläinen
Journal:  Schizophr Res Cogn       Date:  2015-09-09

6.  Long-term cognitive trajectories and heterogeneity in patients with schizophrenia and their unaffected siblings.

Authors:  Md A Islam; T D Habtewold; F D van Es; P J Quee; E R van den Heuvel; B Z Alizadeh; R Bruggeman
Journal:  Acta Psychiatr Scand       Date:  2018-09-21       Impact factor: 6.392

7.  Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction).

Authors:  Joanna Moncrieff; Glyn Lewis; Nick Freemantle; Sonia Johnson; Thomas R E Barnes; Nicola Morant; Vanessa Pinfold; Rachael Hunter; Lyn J Kent; Ruth Smith; Katherine Darton; Robert Horne; Nadia E Crellin; Ruth E Cooper; Stefan Priebe
Journal:  BMJ Open       Date:  2019-11-27       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.